Free Articles

A. Goldhirsch, W. C. Wood, R. D. Gelber, A. S. Coates, B. Thürlimann, H.-J. Senn and Panel Members
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
Annals of Oncology 2007 18: doi:10.1093/annonc/mdm271 July 2007 issue

A Goldhirsch, AS Coates, RD Gelber, JH Glick, B Thürlimann, H-J Senn, On behalf of the St Gallen Expert Panel Members
First—select the target: better choice of adjuvant treatments for breast cancer patients
Annals of Oncology 2006 17: doi:10.1093/annonc/mdl398 December 2006 issue

A. E. Ring, I. E. Smith & P. A. Ellis
Breast Cancer and Pregnancy
Ann Oncol 2005 16: doi:10.1093/annonc/mdi388 December 2005 issue

L. Fallowfield, L. Atkins, S. Catt, A. Cox, C. Coxon, C. Langridge, R. Morris & M. Price
Patients’ preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer
Ann Oncol 2006 17: doi:10.1093/annonc/mdj044 February 2006 issue

A. Goldhirsch, J. H. Glick, R. D. Gelber, A. S. Coates, B. Thu¨rlimann, H.-J. Senn and Panel Members
Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
Ann Oncol 2005 16: doi:10.1093/annonc/mdi326 October 2005 issue

P. A. Kosmidis, H. Ludwig and H. Mellstedt
ESMO at 30: Mission ongoing
Ann Oncol 2005 16: doi:10.1093/annonc/mdi285 September 2005 issue

J. Tabernero, T. Macarulla, F. J. Ramos and J. Baselga
Novel targeted therapies in the treatment of gastric and esophageal cancer
Ann Oncol 2005 16: doi:10.1093/annonc/mdi355 November 2005 issue

G. Macdonald, C. Paltiel, I. A. Olivotto, and S. Tyldesley
A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer
Ann Oncol 2005 16: doi:10.1093/annonc/mdi274 September 2005 issue

C. Bosetti, F. Levi, F. Lucchini, E. Negri, and C. La Vecchia
Lung cancer mortality in European women: recent trends and perspectives
Ann Oncol 2005 16: doi:10.1093/annonc/mdi313 October 2005 issue

G. Bocci, M. Tuccori, U. Emmenegger, V. Liguori, A. Falcone, R. S. Kerbel & M. Del Tacca
Cyclophosphamide-methotrexate ‘metronomic’ chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation
Ann Oncol 2005 16: doi:10.1093/annonc/mdi240 August 2005 issue

S. Mosolits, G. Ullenhag, and H. Mellstedt
Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results
Ann Oncol 2005 16: 847-862. June 2005 issue

K. M. Wasan, P. E. Goss, P. H. Pritchard, L. Shepherd, M. J. Palmer, S. Liu, D. Tu, J. N. Ingle, M. Heath, D. DeAngelis, and E. A. Perez
The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L)
Ann Oncol 2005 16: doi:10.1093/annonc/mdi158 May 2005 issue

P. Boyle and J. Ferlay
Cancer incidence and mortality in Europe, 2004
Ann Oncol 2005 16: 481-488. March 2005 issue

A. Molassiotis, P. Fernadez-Ortega, D. Pud, G. Ozden, J. A. Scott, V. Panteli, A. Margulies, M. Browall, M. Magri, S. Selvekerova, E. Madsen, L. Milovics, I. Bruyns, G. Gudmundsdottir, S. Hummerston, A. M.-A. Ahmad, N. Platin, N. Kearney, and E. Patiraki
Use of complementary and alternative medicine in cancer patients: a European survey
Ann Oncol 2005 16: doi:10.1093/annonc/mdi110 April 2005

J. A. Menendez, L. Vellon, R. Colomer, and R. Lupu
Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (HerceptinTM) in breast cancer cells with Her-2/neu oncogene amplification
Ann Oncol 2005 16: doi:10.1093/annonc/mdi090 March 2005 issue

F. H. van Tiel, M. M. Harbers, A. G. Kessels, and H. C. Schouten
Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia
Ann Oncol 2005 16: 195-205. February 2005 issue

S. M. Crawford and J. Peace
Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary?
Ann Oncol 2005 16: 47-50. January 2005 issue

J. Lorenzo Bermejo and K. Hemminki
Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing
Ann Oncol 2004 15: 1834-1841. December 2004 issue

ESMO/ASCO Task Force on Global Curriculum in Medical Oncology, H. H. Hansen, D. F. Bajorin, H. B. Muss, G. Purkalne, D. Schrijvers, and R. Stahel
Recommendations for a Global Core Curriculum in Medical Oncology
Ann Oncol 2004 15: 1603-1612. November 2004 issue

K. J. Savage, M. Chhanabhai, R. D. Gascoyne, and J. M. Connors
Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification
Ann Oncol 2004 15: 1467-1475. October 2004 issue

D. J. Kerr
A word in your ear: the 2004 Annals of Oncology prizes
Ann Oncol 2004 15: 1303-1304. September 2004 issue

H. J. Schmoll, R. Souchon, S. Krege, P. Albers, J. Beyer, C. Kollmannsberger, S. D. Fossa, N. E. Skakkebaek, R. de Wit, K. Fizazi, J. P. Droz, G. Pizzocaro, G. Daugaard, P. H. M. de Mulder, A. Horwich, T. Oliver, R. Huddart, G. Rosti, L. Paz Ares, O. Pont, J. T. Hartmann, N. Aass, F. Algaba, M. Bamberg, I. Bodrogi, C. Bokemeyer, J. Classen, S. Clemm, S. Culine, M. de Wit, H. G. Derigs, K. P. Dieckmann, M. Flasshove, X. Garcia del Muro, A. Gerl, J. R. Germa-Lluch, M. Hartmann, A. Heidenreich, W. Hoeltl, J. Joffe, W. Jones, G. Kaiser, O. Klepp, S. Kliesch, L. Kisbenedek, K. U. Koehrmann, M. Kuczyk, M. P. Laguna, O. Leiva, V. Loy, M. D. Mason, G. M. Mead, R. P. Mueller, N. Nicolai, G. O. N. Oosterhof, T. Pottek, O. Rick, H. Schmidberger, F. Sedlmayer, W. Siegert, U. Studer, S. Tjulandin, H. von der Maase, P. Walz, S. Weinknecht, L. Weissbach, E. Winter, and C. Wittekind
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
Ann Oncol 2004 15: 1377-1399. September 2004 issue

F. Dimeo, A. Schmittel, T. Fietz, S. Schwartz, P. Kohler, D. Boning, and E. Thiel
Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment
Ann Oncol 2004 15: 1237-1242. August 2004 issue

G. Berclaz, S. Li, K. N. Price, A. S. Coates, M. Castiglione-Gertsch, C.-M. Rudenstam, S. B. Holmberg, J. Lindtner, D. Erien, J. Collins, R. Snyder, B. Thürlimann, M. F. Fey, C. Mendiola, I. Dudley Werner, E. Simoncini, D. Crivellari, R. D. Gelber and A. Goldhirsch
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
Ann Oncol 2004 15: 875-884. June 2004 issue

J. Vardy and I. F. Tannock
Quality of cancer care
Ann Oncol 2004 15: 1001-1006. July 2004 issue

K. Schmidt and E. Ernst
Assessing websites on complementary and alternative medicine for cancer
Ann Oncol 2004 15: 733-742. May 2004 issue

A. Gratwohl, H. Baldomero, T. Demirer, G. Rosti, G. Dini, R. Ladenstein, and A. Urbano-Ispizua on behalf of the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT) in cooperation with the Working Party on Solid Tumours (STWP) and the Working Party on Pediatric Diseases (PDWP
Hematopoetic stem cell transplantation for solid tumors in Europe
Ann Oncol 2004 15: 653-660. April 2004 issue

S. Cresta, G. Grasselli, M. Mansutti, A. Martoni, G. Lelli, G. Capri, F. Buzzi, G. Robustelli Della Cuna, A. Jirillo, E. Terzoli, L. Frevola, E. Tarenzi, C. Sguotti, N. Azli, M. Murawsky, and L. Gianni
A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer
Ann Oncol 2004 15: 433-439. March 2004 issue

G. M. Marx, G. M. Blake, E. Galani, C. B. Steer, S. E. Harper, K. L. Adamson, D. L. Bailey, and P. G. Harper
Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients
Ann Oncol 2004 15: 291-295. February 2004 issue

U. Gatzmeier, G. Groth, C. Butts, N, Van Zandwijk, F. Shepherd, A. Ardizzoni, C. Barton, P. Ghahramani, and V. Hirsh
Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer
Ann Oncol 2004 15: 19-27. January 2004 issue

M. Brada, L. Viviers, C. Abson, F. Hines, J. Britton, S. Ashley, S. Sardell, D. Traish, A. Gonsalves, P. Wilkins, and C. Westbury
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas
Ann Oncol 2003 14: 1715-1721. December 2003 issue

R. Arriagada, M. G. Lê, J.-M. Guinebretière, A. Dunant, F. Rochard, and T. Tursz
Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients
Ann Oncol 14: 1617-1622. November 2003 issue

M. Colleoni, G. Curigliano, I. Minchella, G. Peruzzotti, F. Nolè, G. Mazzarol, G. Renne, L. Orlando, A. Rocca, P. Veronesi, M. Intra, G. Viale, M. T. Sandri, G. Severi, and A. Goldhirsch
Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phase
Ann Oncol 14: 1477-1483. October 2003 issue

F. Di Costanzo, A. Sobrero, S. Gasperoni, L. Dogliotti, L. Frassineti, A. Falcone, R. Lionetto, P. Bruzzi, G. Luppi, L. Gallo, P. Conte, A. Comandone, D. Turci, M. Marzola, U. Folco, E. Pfanner, M. Mestriner, C. Boni, C. Galli, M. Tonato, and R. Rosso
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)
Ann Oncol 14: 1365-1372. September 2003 issue

P. Boyle, A. d?Onofrio, P. Maisonneuve, G. Severi, C. Robertson, M. Tubiana, and U. Veronesi
Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about?
Ann Oncol 14: 1312-1325. August 2003 issue

P. Boyle, P. Autier, H. Bartelink, J. Baselga, P. Boffetta, J. Burn, H. J. G. Burns, L. Christensen, L. Denis, M. Dicato, V. Diehl, R. Doll, S. Franceschi, C. R. Gillis, N. Gray, L. Griciute, A. Hackshaw, M. Kasler, M. Kogevinas, S. Kvinnsland, C. La Vecchia, F. Levi, J. G. McVie, P. Maisonneuve, J. M. Martin-Moreno, J. Newton Bishop, F. Oleari, P. Perrin, M. Quinn, M. Richards, U. Ringborg, C. Scully, E. Siracka, H. Storm, M. Tubiana, T. Tursz, U. Veronesi, N. Wald, W. Weber, D. G. Zaridze, W. Zatonski, and H. zur Hausen
European Code Against Cancer and scientific justification: third version (2003)
Ann Oncol 14: 973-1005. July 2003 issue

G. Parmiani, L. Pilla, C. Castelli, and L. Rivoltini
Vaccination of patients with solid tumours
Ann Oncol 14: 817-824. June 2003 issue

C. Bernard-Marty, M. Mano, M. Paesmans, C. Accettura, R. Munoz-Bermeo, T. Richard, K. Kleiber, F. Cardoso, J. P. Lobelle, D. Larsimont, M. J. Piccart, and A. Di Leo
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients
Ann Oncol 14: 693-698. May 2003 issue

C. Dazzi, A. Cariello, P. Giovanis, M. Monti, B. Vertogen, M. Leoni, A. Tienghi, D. Turci, G. Rosti, O. Nanni, C. Rondoni, and M. Marangolo
Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study
Ann Oncol 14: 559-563. April 2003 issue

J. Kerr, J. Engel, A. Schlesinger-Raab, H. Sauer, and D. H?lzel
Communication, quality of life and age: results of a 5-year prospective study in breast cancer patients
Ann Oncol 14: 421-427. March 2003 issue

A. J. van de Wouw, R. L. H. Jansen, E. J. M. Speel, and H. F. P. Hillen
The unknown biology of the unknown primary tumour: a literature review
Ann Oncol 14: 191-196. February 2003 issue

S. Conroy, C. Newman, and S. Gudka
Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in children
Ann Oncol 14: 42-47. January 2003 issue

P. J. Souquet, E. H. Tan, J. Rodrigues Pereira, R. Van Klaveren, A. Price, U. Gatzemeier, M. Jaworski, J. P. Burillon, and D. Aubert
GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine?cisplatin with vinorelbine?ifosfamide?cisplatin in metastatic non-small-cell lung cancer patients
Ann Oncol 13: 1853-1861. December 2002 issue

E. Heidemann, H. Stoeger, R. Souchon, W.-D. Hirschmann, H. Bodenstein, C. Oberhoff, J. T. Fischer, M. Schulze, M. Clemens, R. Andreesen, M. Mahlke, M. K?nig, A. Scharl, K. Fehnle, and M. Kaufmann
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial
Ann Oncol 13: 1717-1729. November 2002 issue

R. Rosell, U. Gatzemeier, D. C. Betticher, U. Keppler, H. N. Macha, R. Pirker, P. Berthet, J. L. Breau, P. Lianes, M. Nicholson, A. Ardizzoni, A. Chemaissani, J. Bogaerts, and G. Gallant
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial
Ann Oncol 13: 1539-1549. October 2002 issue

R. Arriagada, M. Spielmann, S. Koscielny, T. Le Chevalier, T. Delozier, M. Ducourtieux, T. Tursz, and C. Hill
Patterns of failure in a randomized trial of adjuvant chemotherapy in postmenopausal patients with early breast cancer treated with tamoxifen
Ann Oncol 13: 1378-1386. September 2002 issue

M. Ducreux, P. Rougier, J.-P. Pignon, J.-Y. Douillard, J.-F. Seitz, R. Bugat, J.-F. Bosset, Y. Merouche, J.-L. Raoul, M. Ychou, A. Adenis, F. Berthault-Cvitkovic, and M. Luboinski
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
Ann Oncol 13: 1185-1191. August 2002 issue

A. T. C. Chan, P. M. L. Teo, and P. J. Johnson
Nasopharyngeal carcinoma
Ann Oncol 13: 1007-1015. July 2002 issue.

A. Micheli, E. Mugno, V. Krogh, M. J. Quinn, M. Coleman, T. Hakulinen, G. Gatta, F. Berrino, R. Capocaccia, and the EUROPREVAL Working Group
Cancer prevalence in European registry areas
Ann Oncol 13: 840-865. June 2002 issue.

B. V. Jensen, T. Skovsgaard, and S. L. Nielsen
Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120
Ann Oncol 13: 699-709. May 2002 issue.

A. J. M. Ferreri, J.-Y. Blay, M. Reni, F. Pasini, A. Gubkin, U. Tirelli, A. Calderoni, E. Zucca, S. Cortelazzo, C. Chassagne, M. Tinguely, B. Borisch, F. Berger, M. Ponzoni and F. Cavalli
Relevance of intraocular involvement in the management of primary central nervous system lymphomas
Ann Oncol 13: 531-538. April 2002 issue.